Australia markets closed

HTG Molecular Diagnostics Inc (65H.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.24200.0000 (0.00%)
At close: 04:28PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,214
6,366
8,907
8,549
Cost of revenue
4,867
4,572
4,095
3,992
Gross profit
1,348
1,794
4,812
4,557
Operating expenses
Research development
6,474
6,782
6,089
6,080
Selling general and administrative
14,462
15,842
16,547
18,063
Total operating expenses
20,936
22,624
22,636
24,143
Operating income or loss
-19,588
-20,830
-17,824
-19,586
Interest expense
745.818
856.731
1,065
1,025
Total other income/expenses net
-
8.333
1,736
-500.126
Income before tax
-20,139
-21,584
-17,123
-20,856
Income tax expense
12.669
10.837
22.475
14.415
Income from continuing operations
-20,152
-21,594
-17,145
-20,870
Net income
-20,152
-21,594
-17,145
-20,870
Net income available to common shareholders
-20,152
-21,594
-17,145
-20,870
Basic EPS
-16.83
-24.28
-29.64
-54.12
Diluted EPS
-16.83
-24.28
-29.64
-54.12
Basic average shares
1,276
889.284
578.01
385.659
Diluted average shares
1,276
889.284
578.01
385.659